Net profit of Novo Nordisk 2009-2019

The net profit for the year of the Danish pharmaceutical company Novo Nordisk increased annually during the period from 2009 to 2019, although with a stagnation from 2016 onwards. In 2009, the net profit was around 9.6 billion Danish kroner, and in 2019, this amount had increased to around 40 billion Danish kroner.

Annual net profit of Novo Nordisk from 2009 to 2019

Net profit in million DKK
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2009 to 2019

Supplementary notes

Some figures have been taken from previous publications.

Novo Nordisk is a Danish pharmaceutical company founded in 1923. The company's key product is diabetes medication, but does also produce pharmaceuticals for other use.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Denmark "

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.